IHS Chemical Week

Regions :: Western Europe :: Switzerland

Lonza Signs Manufacturing Deal with Femta Pharmaceuticals

10:22 PM MST | December 15, 2009 | Deepti Ramesh

Lonza says it has signed a manufacturing services agreement with Femta Pharmaceuticals (San Diego, CA), to facilitate the development and manufacturing of FM101, a high affinity monoclonal antibody in late pre-clinical development for the treatment of rheumatoid arthritis. The agreement gives Femta access to Lonza’s GS Gene Expression System along with cell line, purification and process development to support a cGMP process for Femta’s clinical development program. “By leveraging Lonza’s considerable expertise in gene expression and...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa